JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on the study of the research work of Dr Paul Squires and his colleagues at the University of Warwick. Dr Paul Squires and Dr Claire Hills from the School of Life Sciences (SLS) at the University of Warwick […]

Phoenix, Arizona – Today, at the Society of Toxicology’s 53rd Annual Meeting, Hepregen Corporation, a leader in the development of next generation HepatoPacTM and HepatoMuneTM cell-based in vitro assay products announced the commercial launch of the company’s first HepatoPacTM kit designed specifically for toxicology applications. The kit contains one or more standard 96-well tissue culture […]

Franklin Lakes, N.J. — BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced the election of Dr. Claire Pomeroy to its Board of Directors. Dr. Pomeroy, 58, is an expert in infectious diseases and a long-time advocate for public health and patients, especially those with HIV/AIDS. She is currently President of […]

CHALFONT ST. GILES, UK — GE (NYSE:GE) announced today that it has completed the acquisition of Thermo Fisher’s HyClone™ cell culture media and sera, and gene modulation and magnetic beads businesses. The acquisition allows GE to expand its offering of tools, technologies and services for the discovery and manufacture of innovative new medicines, vaccines and […]

WALTHAM, Mass. – Thermo Fisher Scientific (NYSE:TMO), the world leader in serving science, today announced that it has completed the sale of its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare, a unit of General Electric Company (NYSE: GE), for $1.065 billion. The businesses will become part of GE […]

Columbia, Maryland — In Vitro ADMET Laboratories, LLC (IVAL) and Taconic announced an agreement today under which IVAL will prepare cryopreserved hepatocytes derived from Taconic’s knockout and genetically humanized mouse models for use in preclinical drug development research. The resulting plateable cryopreserved hepatocytes will be a commercial product available from either company. Using hepatocytes from […]

Schlieren, Switzerland and Rockville, Maryland — InSphero AG today announced a collaboration with the National Institutes of Health’s (NIH) National Center for Advancing Translational Sciences (NCATS) to identify anti-cancer agents with cytotoxic activity in 3D culture models. The project includes development of multi-cell type spheroids (MCTS) by InSphero in the company’s 96- and 384-well GravityPLUS™ […]

Belfast — Andor Technology, an Oxford Instruments company and world leaders in scientific imaging and spectroscopy solution, today announced the launch of the new Solis 64-bit acquisition software for imaging and spectroscopy. Solis is now a fully 64-bit enabled application for Windows (XP, Vista 7 and 8) offering rich functionality for data acquisition and processing. […]

Symcel — the company behind the revolutionary cellbased assay tool providing real time cellular bioenergetics measurements — has announced the commercial readiness of its calScreener system, over 10 years in development. Since the technology has moved from its prototype into a fully functional commercial platform, three units have been installed at leading international research institutions […]

MEDFORD, MA – Hepregen Corporation, a leader in the development of next generation HepatoPac™ and HepatoMune™ cell-based in vitro assay products, announced today the commercial launch of the Company’s first HepatoPac™ kit designed specifically for use in evaluating metabolic turnover of chemicals in the human liver. The kit contains one or more standard 96-well tissue […]